“…The steadily growing availability of genome sequences coinciding with improved performance and also dropping costs of mass spectrometers and software will give rise to next-generation MALDI-TOF MS applications in bacteriology. Some trends for novel technologies are becoming apparent, e.g., proteome-based approaches (Intelicato-Young & Fox, 2013), S10-GERMS method (Tamura, Hotta, & Sato, 2013), SELDI-TOF MS (Dubska et al, 2011), imaging MALDI-TOF MS (Yang et al, 2012) and even beyond strain-level differentiation such as discrimination of metabolic states (Kuehl, Marten, Bischoff, Brenner-Weiss, & Obst, 2011) or tracking the transition from susceptibility to resistance against antibiotics (Kostrzewa, Sparbier, Maier, & Schubert, 2013;Shah et al, 2011). These studies raise expectations for further innovation in MALDI-TOF MS and its novel potential in microbiology.…”